COMMUNIQUÉS West-GlobeNewswire

Lanier Recovery Center earns BBB accreditation and A rating
14/07/2026
New Suwanee rehab builds a credentials-first program, earning BBB accreditation less than a year after opening Suwanee, GA, July 14, 2026 (GLOBE NEWSWIRE) -- Lanier Recovery Center has earned accreditation from the [...]
Inner Voyage Recovery Center earns BBB accreditation and A+ rating after eight years serving the Atlanta region
14/07/2026
Woodstock drug and alcohol rehab adds Better Business Bureau accreditation to its existing credentials — a reflection of nearly a decade of transparent, accountable care for individuals and families across Georgia [...]
Guardian Initiative Seeks Community and Corporate Sponsors Ahead of September 28 Charity Golf Tournament Benefiting Military, Veterans, First Responders, and Their Families
14/07/2026
With limited time remaining before the event, businesses and community leaders are encouraged to support a mission that delivers life-changing healthcare to those who have dedicated their lives to serving others. San [...]
Applied Biologics Announces Successful Manufacture of First Research Construct for Disease-Modifying Osteoarthritis Gene Therapy Program
14/07/2026
SCOTTSDALE, Ariz., July 14, 2026 (GLOBE NEWSWIRE) -- Applied Biologics, a biopharmaceutical company advancing novel biologic therapies for serious diseases with significant unmet medical needs, today announced the [...]
Nordastro Launches Fully Personalized Astrology Book With Companion App for Daily Guidance
14/07/2026
New System Generates a Custom Printed Book From Each Reader's Birth Chart, Paired With Compatibility Tools and Daily Insights NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Nordastro has launched a personalized astrology [...]
Genopore appoints Rey Mali as Chief Executive Officer to accelerate growth of the pioneering protein identification company
14/07/2026
SAN FRANCISCO and YAVNE, Israel, July 14, 2026 (GLOBE NEWSWIRE) -- Genopore, the next-generation proteomics company developing the first semiconductor based optical nanopore technology platform with AI/ML analysis for [...]
SRX Global Reports Paper-Traded EMJX Return of ~25% Since February 11, 2026
14/07/2026
EMJX Shifted from “Stress” to “Mixed” for Bitcoin Company Files Updated Investor Presentation Outlining Performance and Strategy Management to Host Fireside Chat Today at 10:30am ET NORTH PALM BEACH, Fla., July 14, 2026 [...]
Biogen Presents Phase 2 CELIA Data at AAIC Demonstrating Meaningful Clinical Outcomes and Robust Tau Reduction with Diranersen in Early Alzheimer’s Disease
14/07/2026
Clinical outcomes : Diranersen demonstrated efficacy across all studied doses at 18 months, with consistent results across multiple prespecified clinical endpoints; the 60 mg dose showed the strongest response with [...]
Ernexa Therapeutics CEO Corner Highlights Differentiated ERNA-101 Platform as Company Advances Toward Planned First-in-Human Phase 1 Study in 2026
14/07/2026
CEO discusses ERNA-101's potential to transform immunologically "cold" tumors into tumors the immune system can recognize and kill Video highlights compelling preclinical data, differentiated off-the-shelf iMSC platform [...]
Dandy Unveils Polychromatic Shade™ to End the Trade-Off Between Dental Aesthetics and Affordability
14/07/2026
Breakthrough innovation delivers natural-looking zirconia crowns and bridges at a fraction of the cost of hand-painted porcelain NEW YORK, July 14, 2026 (GLOBE NEWSWIRE) -- Dandy , the fully digital dental lab, today [...]
ASPN 2026 to Feature Three Abstracts on SPRINT® PNS
14/07/2026
- 12-Month Outcomes from the RESET™ Trial for Low Back Pain Recognized as Top Abstract Award winner - CLEVELAND, July 14, 2026 (GLOBE NEWSWIRE) -- Pain medicine physicians from across the U.S. will continue to expand [...]
Aeroflow Sleep Donates to Beds for Kids and Project Sleep to Improve Sleep Health Equity
14/07/2026
Both donations reinforce Aeroflow Sleep’s commitment to closing gaps in healthcare access and promoting healthy sleep for all ASHEVILLE, N.C., July 14, 2026 (GLOBE NEWSWIRE) -- Aeroflow Sleep , a nationwide provider of [...]
XOMA Royalty Announces Closing of Its Acquisition by Ligand
14/07/2026
EMERYVILLE, Calif., July 14, 2026 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation today announced that Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) has completed its previously announced acquisition of XOMA Royalty. [...]
Ligand Completes Acquisition of XOMA Royalty, Creating a Portfolio of More than 200 Biopharmaceutical Royalty Assets
14/07/2026
Acquisition adds seven commercial products including VABYSMO® (faricimab-svoa), OJEMDA™ (tovorafenib), and MIPLYFFA® (arimoclomol), and more than 100 development and commercial-stage assets, creating long-term [...]
Inhibikase Therapeutics Announces Sale of $50 Million of Shares Through its At-the-Market (ATM) Facility
14/07/2026
WILMINGTON, Del., July 14, 2026 (GLOBE NEWSWIRE) -- Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (“Inhibikase” or “Company”), a clinical-stage pharmaceutical company developing IKT-001 for Pulmonary Arterial Hypertension [...]
Cannara Announces a Long-Term International Cannabis Supply Agreement with Curaleaf International Limited
14/07/2026
MONTREAL, July 14, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (“ Cannara ”, the “ Company ”, “ us ” or “ we ”) ( TSX: LOVE ) ( OTCQX: LOVFF ) ( FRA: 8CB0 ), a vertically integrated producer of premium-grade cannabis [...]
Immutep Secures Fourth United States Patent for Eftilagimod Alfa in Combination with a PD-1 Pathway Inhibitor
14/07/2026
SYDNEY, AUSTRALIA, July 14, 2026 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a biotechnology company developing novel immunotherapies, today announced the grant of a new [...]
Cannara annonce la conclusion d’une entente internationale à long terme d’approvisionnement en cannabis avec Curaleaf International Limited
14/07/2026
MONTRÉAL, 14 juill. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », la « Société », « nous ») ( TSX: LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), producteur verticalement intégré de cannabis de qualité [...]
AEON Biopharma Announces Pricing of Upsized $13.75 Million Public Offering with Accompanying Milestone Warrants Providing Potential for Additional Future Funding
14/07/2026
$13.75 million underwritten public offering with up to an additional $29.6 million in potential proceeds tied to the cash exercise in full of the milestone warrants issued in the offering IRVINE, Calif., July 14, 2026 ( [...]

Pages